Rafferty Asset Management’s EyePoint Pharmaceuticals EYPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-10,980
Closed -$81.8K 1095
2024
Q4
$81.8K Sell
10,980
-465
-4% -$3.46K ﹤0.01% 1130
2024
Q3
$91.4K Buy
11,445
+931
+9% +$7.44K ﹤0.01% 1131
2024
Q2
$91.5K Sell
10,514
-1,588
-13% -$13.8K ﹤0.01% 1162
2024
Q1
$250K Buy
+12,102
New +$250K ﹤0.01% 1045